Overview
McDermott Will & Emery has advised shareholders and management of Porsolt Group, on Apax Partners’ majority stake to support its growth strategy to become a global leader in preclinical services.
Apax’s investment, together with the management and current shareholders of the company, will allow Porsolt to further grow and implement its strategy to become a comprehensive preclinical service company, addressing the varying therapeutical areas of the global Pharma, Biotech, and research communities.
McDermott team was composed of :
• Emmanuelle Trombe, partner, on Life Sciences aspects
• Henri Pieyre de Mandiargues, partner, Fanny Rech, counsel, and Alice Sevestre, associate, on corporate aspects
• Pierre-Arnoux Mayoly, partner, Elizabeth Amzallag, associate, on financing aspects
• Jilali Maazouz, partner, Abdel Abdellah and Anne-Lorraine Méreaux, associates, on employment aspects
• Come de Saint Vincent, counsel, on tax aspects
